Literature DB >> 4032539

Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.

B Bassil, D E Dosoretz, G R Prout.   

Abstract

A retrospective analysis of 252 patients with renal cell carcinoma was performed with the tumor, nodes and metastasis system of cancer staging. Each patient received a clinical and a pathological classification. Patient survival was calculated for each pT stage. All patients with stage pT1 disease (100 per cent) were alive at 5 years, as were 91 per cent of those with stage pT2 tumors. Higher T stages showed poorer survival; 58 per cent of the patients with stage pT3 and only 25 per cent with stage pT4 tumors were alive at 5 years. Invasion into the inferior vena cava (pT3c) had an adverse effect on survival, which was statistically significant compared to patients in the pT3a and pT3b subgroups. The type of surgical procedure performed had no influence on ultimate survival, nor did the use of adjuvant radiation therapy. The tumor, nodes and metastasis system clearly documents that the survival of patients with renal cell carcinoma depends on the local extent of the primary tumor, determined at the time of surgical exploration.

Entities:  

Mesh:

Year:  1985        PMID: 4032539     DOI: 10.1016/s0022-5347(17)47235-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  The role of resection for patients with renal carcinoma.

Authors:  R C Flanigan; P M Yonover
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 2.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

3.  Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.

Authors:  F Porzsolt; D Messerer; R Hautmann; A Gottwald; H Sparwasser; K Stockamp; W Aulitzky; J G Moormann; K Schumacher; H Rasche
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 5.  Risk factors, classification, and staging of renal cell cancer.

Authors:  Damian A Laber
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 6.  [Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection].

Authors:  M Löhr; D Rohde
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

7.  Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines.

Authors:  H H Kirchner; P Anton; J Atzpodien
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Report on two cases.

Authors:  S Arakawa; G Hamami; K Umezu; S Kamidono; J Ishigami; S Arakawa
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 9.  Imaging in the staging of renal cell carcinoma.

Authors:  R H Reznek
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 10.  Metastatic renal cell carcinoma.

Authors:  Robert C Flanigan; Steven C Campbell; Joseph I Clark; Maria M Picken
Journal:  Curr Treat Options Oncol       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.